108 related articles for article (PubMed ID: 37309821)
21. Interventions for maintenance of surgically induced remission in Crohn's disease: a network meta-analysis.
Iheozor-Ejiofor Z; Gordon M; Clegg A; Freeman SC; Gjuladin-Hellon T; MacDonald JK; Akobeng AK
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD013210. PubMed ID: 31513295
[TBL] [Abstract][Full Text] [Related]
22. Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events.
Alkabbani W; Pelletier R; Gamble JM
Am J Epidemiol; 2021 Aug; 190(8):1572-1581. PubMed ID: 33751032
[TBL] [Abstract][Full Text] [Related]
23. Online tools to synthesize real-world evidence of comparative effectiveness research to enhance formulary decision making.
Chen S; Graff J; Yun S; Beal B; Ta JT; Bansal A; Carlson JJ; Veenstra DL; Basu A; Devine B
J Manag Care Spec Pharm; 2021 Jan; 27(1):95-104. PubMed ID: 33377442
[TBL] [Abstract][Full Text] [Related]
24. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
[TBL] [Abstract][Full Text] [Related]
25. Laser peripheral iridoplasty for chronic angle closure.
Bayliss JM; Ng WS; Waugh N; Azuara-Blanco A
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD006746. PubMed ID: 33755197
[TBL] [Abstract][Full Text] [Related]
26. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.
Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L
Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods.
Hong H; Wang C; Rosner GL
Clin Trials; 2021 Feb; 18(1):3-16. PubMed ID: 33258698
[TBL] [Abstract][Full Text] [Related]
28. Household interventions for secondary prevention of domestic lead exposure in children.
Nussbaumer-Streit B; Mayr V; Dobrescu AI; Wagner G; Chapman A; Pfadenhauer LM; Lohner S; Lhachimi SK; Busert LK; Gartlehner G
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD006047. PubMed ID: 33022752
[TBL] [Abstract][Full Text] [Related]
29. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
Webster J; Smith BD
Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
[TBL] [Abstract][Full Text] [Related]
30. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
31. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
32. Treatments for seizures in catamenial (menstrual-related) epilepsy.
Maguire MJ; Nevitt SJ
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013225. PubMed ID: 34528245
[TBL] [Abstract][Full Text] [Related]
33. Trial designs using real-world data: The changing landscape of the regulatory approval process.
Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
[TBL] [Abstract][Full Text] [Related]
34. Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
Liu J; Li L; Li S; Wang Y; Qin X; Deng K; Liu Y; Zou K; Sun X
Diabetes Obes Metab; 2020 Sep; 22(9):1619-1627. PubMed ID: 32364674
[TBL] [Abstract][Full Text] [Related]
35. Payer perceptions of the use of real-world evidence in oncology-based decision making.
Brixner D; Biskupiak J; Oderda G; Burgoyne D; Malone DC; Arondekar B; Niyazov A
J Manag Care Spec Pharm; 2021 Aug; 27(8):1096-1105. PubMed ID: 34337998
[No Abstract] [Full Text] [Related]
36. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
[TBL] [Abstract][Full Text] [Related]
37. DESIGN DIFFERENCES EXPLAIN VARIATION IN RESULTS BETWEEN RANDOMIZED TRIALS AND THEIR NON-RANDOMIZED EMULATIONS.
Heyard R; Held L; Schneeweiss S; Wang SV
medRxiv; 2023 Jul; ():. PubMed ID: 37502999
[TBL] [Abstract][Full Text] [Related]
38. Surgical or radiological treatment for varicoceles in subfertile men.
Persad E; O'Loughlin CA; Kaur S; Wagner G; Matyas N; Hassler-Di Fratta MR; Nussbaumer-Streit B
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD000479. PubMed ID: 33890288
[TBL] [Abstract][Full Text] [Related]
39. A bias-corrected meta-analysis model for combining, studies of different types and quality.
Verde PE
Biom J; 2021 Feb; 63(2):406-422. PubMed ID: 32996196
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
